Chronix Teams with Hemispherx on Chronic Fatigue MDx

Chronix is developing a test based on its circulating DNA detection technology that will be tested in studies of how patients respond to Hemispherx's experimental drug Ampligen.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories